A.M. Vitals: Breast Cancer Awareness, Twitter Research and Japan’s Contested Pharma Market


Published On: September 30th, 2011

 

Too much pink in October?

A USA Today poll finds that, while nearly everyone supports Breast Cancer Awareness Month, a third of those surveyed think it steals too much of the spotlight from other maladies like melanoma and is overly commercialized.

Big Pharma’s newest battleground: Japan. Although much of the pharma industry’s growth talk centers around emerging markets like China and India, companies like Lilly, Merck, Pfizer and Novartis are also ratcheting up their efforts in the world’s second largest drugs market, the WSJ reports.

Twitter, now a behavioral science research tool. Guess what researchers studying Twitter messages discovered? People are more positive when they’re not working and the sun is out, the NY Times says, summing up the study by Cornell University sociologists in the journal Science.

Read more: 
A.M. Vitals: Breast Cancer Awareness, Twitter Research and Japan’s Contested Pharma Market

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


Racial and ethnic minorities are not only more likely to be diagnosed with cancer, they are also more likely to receive less timely and effective treatment. Because of these disparities, cancer takes a greater toll on communities of color

Related Posts

  • A.M. Vitals: Breast Cancer Research Covers Radiation Treatment
    Breast-Cancer Developments: Research presented at the San Antonio Breast Cancer Symposium found that a genetic test called Oncotype DX can help pinpoint the patients with ductal carcinoma in situ, a very early form of breast cancer, who stand to benefit from post-surgical radiation treatment, the WSJ reports . Meantime, a separate study found that partial..
  • A.M. Vitals: Silicone Breast Implants Carry Risks, But Will Stay on the Market
    Implant Review: The FDA says silicone breast implants will stay on the market because the risks — including scarring and hardening around the implants and a 20% chance that they’ll need to be removed within a decade — are well enough understood by women who decide to have them, the WSJ reports . The agency’s..
  • A.M. Vitals: Sanofi Reports Breast Cancer Drug Setback
    Also: Arena’s woes worsen; good news on Tarceva from Roche; new HHS report says insurance exchanges will help. ..
  • A.M. Vitals: Roche Will Get Hearing on Avastin For Breast Cancer
    Avastin Appeal: The FDA has granted Roche a late June hearing at which the company will try to convince the agency not to remove the breast-cancer indication for the drug Avastin, the WSJ reports . In December the FDA recommended Avastin no longer be approved for breast cancer , saying the drug hasn’t been shown..
  • A.M. Vitals: E.U. Backs Roche’s Avastin for Breast Cancer
    Avastin Announcement: Roche says its drug Avastin, which the FDA has recommended stripping of its breast-cancer indication, has been backed for that purpose in Europe, the WSJ reports . The drug is used in combination with chemotherapy in breast-cancer patients, but the FDA has said its safety and efficacy aren’t sufficient to warrant its use..
  • A.M. Vitals: Study Highlights Value of Less Invasive Breast Cancer Treatments
    Also: Republicans propose de-funding family-planning; VA wants the Supreme Court to take up health overhaul now; new Smith & Nephew CEO. ..
Leave a comment
Comments are closed.
« Getting the Answers to “Will This Hurt?” All Drug Marketing Is Local »